Efficacy and safety of omalizumab (Xolair®) for cholinergic...

  • Main
  • 2019 / 1
  • Efficacy and safety of omalizumab (Xolair®) for cholinergic...

Efficacy and safety of omalizumab (Xolair®) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: a randomized mixed double-blind and open-label placebo-controlled clinical trial

Gastaminza, Gabriel, Azofra, Julian, Nunez-Cordoba, Jorge M., Baeza, Maria Luisa, Echechipía, Susana, Gaig, Pere, García, Blanca Esther, Labrador-Horrillo, Moises, Sala-Cunill, Ana, Brescó, Marina Sab
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Journal of Allergy and Clinical Immunology: In Practice
DOI:
10.1016/j.jaip.2018.12.025
Date:
January, 2019
File:
PDF, 1.55 MB
english, 2019
Conversion to is in progress
Conversion to is failed